These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
532 related items for PubMed ID: 28473457
1. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7. Kornecook TJ, Yin R, Altmann S, Be X, Berry V, Ilch CP, Jarosh M, Johnson D, Lee JH, Lehto SG, Ligutti J, Liu D, Luther J, Matson D, Ortuno D, Roberts J, Taborn K, Wang J, Weiss MM, Yu V, Zhu DXD, Fremeau RT, Moyer BD. J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457 [Abstract] [Full Text] [Related]
2. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V. Moyer BD, Murray JK, Ligutti J, Andrews K, Favreau P, Jordan JB, Lee JH, Liu D, Long J, Sham K, Shi L, Stöcklin R, Wu B, Yin R, Yu V, Zou A, Biswas K, Miranda LP. PLoS One; 2018 Jul; 13(5):e0196791. PubMed ID: 29723257 [Abstract] [Full Text] [Related]
4. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain. Li Y, North RY, Rhines LD, Tatsui CE, Rao G, Edwards DD, Cassidy RM, Harrison DS, Johansson CA, Zhang H, Dougherty PM. J Neurosci; 2018 Jan 31; 38(5):1124-1136. PubMed ID: 29255002 [Abstract] [Full Text] [Related]
5. Voltage-gated sodium channel function and expression in injured and uninjured rat dorsal root ganglia neurons. Yin R, Liu D, Chhoa M, Li CM, Luo Y, Zhang M, Lehto SG, Immke DC, Moyer BD. Int J Neurosci; 2016 Jan 31; 126(2):182-92. PubMed ID: 25562420 [Abstract] [Full Text] [Related]
7. Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches. Gonçalves TC, Boukaiba R, Molgó J, Amar M, Partiseti M, Servent D, Benoit E. Neuropharmacology; 2018 May 01; 133():404-414. PubMed ID: 29474819 [Abstract] [Full Text] [Related]
8. Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes. Horishita T, Yanagihara N, Ueno S, Okura D, Horishita R, Minami T, Ogata Y, Sudo Y, Uezono Y, Sata T, Kawasaki T. Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec 01; 390(12):1255-1270. PubMed ID: 28905186 [Abstract] [Full Text] [Related]
10. 3'-O-Methylorobol Inhibits the Voltage-Gated Sodium Channel Nav1.7 with Anti-Itch Efficacy in A Histamine-Dependent Itch Mouse Model. Zhang F, Wu Y, Xue S, Wang S, Zhang C, Cao Z. Int J Mol Sci; 2019 Dec 01; 20(23):. PubMed ID: 31805638 [Abstract] [Full Text] [Related]
14. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS. Proc Natl Acad Sci U S A; 2007 May 15; 104(20):8520-5. PubMed ID: 17483457 [Abstract] [Full Text] [Related]
15. Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons. Rush AM, Craner MJ, Kageyama T, Dib-Hajj SD, Waxman SG, Ranscht B. Eur J Neurosci; 2005 Jul 15; 22(1):39-49. PubMed ID: 16029194 [Abstract] [Full Text] [Related]
16. Bulleyaconitine A attenuates hyperexcitability of dorsal root ganglion neurons induced by spared nerve injury: The role of preferably blocking Nav1.7 and Nav1.3 channels. Xie MX, Yang J, Pang RP, Zeng WA, Ouyang HD, Liu YQ, Liu XG. Mol Pain; 2018 Jul 15; 14():1744806918778491. PubMed ID: 29783906 [Abstract] [Full Text] [Related]
17. A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability. Payne CE, Brown AR, Theile JW, Loucif AJ, Alexandrou AJ, Fuller MD, Mahoney JH, Antonio BM, Gerlach AC, Printzenhoff DM, Prime RL, Stockbridge G, Kirkup AJ, Bannon AW, England S, Chapman ML, Bagal S, Roeloffs R, Anand U, Anand P, Bungay PJ, Kemp M, Butt RP, Stevens EB. Br J Pharmacol; 2015 May 15; 172(10):2654-70. PubMed ID: 25625641 [Abstract] [Full Text] [Related]
18. TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury. He XH, Zang Y, Chen X, Pang RP, Xu JT, Zhou X, Wei XH, Li YY, Xin WJ, Qin ZH, Liu XG. Pain; 2010 Nov 15; 151(2):266-279. PubMed ID: 20638792 [Abstract] [Full Text] [Related]
19. Nav1.8 in small dorsal root ganglion neurons contributes to vincristine-induced mechanical allodynia. Nascimento de Lima AP, Zhang H, Chen L, Effraim PR, Gomis-Perez C, Cheng X, Huang J, Waxman SG, Dib-Hajj SD. Brain; 2024 Sep 03; 147(9):3157-3170. PubMed ID: 38447953 [Abstract] [Full Text] [Related]
20. Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action. Gilchrist JM, Yang ND, Jiang V, Moyer BD. Mol Pharmacol; 2024 Feb 15; 105(3):233-249. PubMed ID: 38195157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]